Delivery Order SPE2DB20D1100-SPE2DB25FD7Z7
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $7,451.89 to AmerisourceBergen Drug Corp for the supply of Jemperli 500 mg/10 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, due for completion by August 11, 2025. The awardee, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,903.78 on April 24, 2025, for the supply of JEMPERLI 500 mg/10 ml vials. This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by May 15, 2025. The award is funded by the Department of Defense through its Medical Supply Chain organization and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $29,807.56 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Jemperli 500 mg/10 ml vials. This is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Jemperli 500 mg/10 mL vials. This is a firm fixed-price delivery order with a ceiling value of $22,355.67 and an ultimate completion date of September 16, 2025. The contract represents a non-competitive set-aside award, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $119,230.24 to AmerisourceBergen Drug Corp for the supply of Jemperli 500 mg/10 mL vials. This firm fixed price, non-set-aside delivery order is scheduled for completion by August 15, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal healthcare systems, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Jemperli 500 mg/10 mL vials with a ceiling value of $14,903.78. This is a firm fixed price delivery order under a child contract with no set-aside designation, requiring performance and completion by August 29, 2025. The drug will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $113,363.90 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of JEMPERLI 500 MG/10 ML VIAL 10ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The Defense Logistics Agency awarded a delivery order valued at approximately $29.8K to AmerisourceBergen Drug Corp for the supply of Jemperli 500 mg/10 mL vials. The contract was competitively awarded without set-aside provisions and carries a firm fixed-price structure, with an ultimate completion date of September 23, 2025. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. Jemperli is a specialized pharmaceutical product used in oncology treatment,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $34,009.17 firm fixed-price contract is for the supply of the prescription drug JEMPERLI 500 MG/10 ML VIAL 10ML. There is no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $37,259.45 on September 3, 2025, for the supply of Jemperli 500 mg/10 mL vials. This firm fixed-price, non-set-aside contract is scheduled for completion by September 24, 2025, with performance at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Jemperli (venetoclax) is a targeted cancer therapy used in the treatment of hematologic malignancies, representing a specialized...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD7Z7Delivery Order
The Defense Logistics Agency awarded a $37,259.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of JEMPERLI 500 mg/10 mL vials. This non-set-aside competitive award was issued on August 1, 2025, with an ultimate completion date of August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. JEMPERLI is a specialized pharmaceutical product, and this order represents one of many delivery orders the company fulfills under its broader federal medical supply contracts. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including critical medications, vaccines, and specialized medical commodities across multiple therapeutic domains. As a major pharmaceutical distributor and key federal healthcare vendor, AmerisourceBergen regularly fulfills such orders for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.3k | 8/1/25 |